about
Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes.Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells.Characterization and Immunoregulatory Properties of Innate Pro-B-Cell Progenitors.Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand.Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model.Interaction of vinblastine analogues with tubulin.The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis.Mechanisms of downmodulation and release of tumour necrosis factor receptor induced by human immunodeficiency virus type 1 in human monocytes.CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment.Lymphoid Gene Upregulation on Circulating Progenitors Participates in Their T-Lineage Commitment.Benzodiazepine anesthesia in humans modulates the interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6 responses of blood monocytes.G-CSF mobilizes CD34 + regulatory monocytes that inhibit graft-versus-host diseaseReconstitution of peripheral benzodiazepine receptor expression in X-linked chronic granulomatous disease by interferon-gammaCa2+-channel blockers modulate the oxidative burst induced with arachidonic acid in macrophage-like P 388D1 cells. Interaction with peripheral benzodiazepinesBenzodiazepines and PK 11195 exert immunomodulating activities by binding on a specific receptor on macrophagesIn vivo immunomodulating activity of PK 1195, a structurally unrelated ligand for "peripheral" benzodiazepine binding sites--I. Potentiation in mice of the humoral response to sheep red blood cellsInduction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytesSoluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activityTreatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cellsFas receptor signaling is requisite for B cell differentiationRole of GM-CSF in tolerance induction by mobilized hematopoietic progenitorsG-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse
P50
Q34008199-9DA2CB08-11FA-4412-9267-5175AE96F261Q37089055-28059587-675E-457C-8260-A9939AC9834EQ38623809-461D5786-A991-4197-975B-B73D1CC0FBF3Q42509804-C1A6143A-BF8E-42F9-B0AF-77F029B6B99EQ42981580-BFF5CE2D-8114-4F8E-B9F7-5BA877677F58Q43903471-EC299077-12FA-443D-8FD7-E0FE73B46CDDQ45729149-10DE065D-11A9-4C8D-B192-5147834C2D7BQ45764278-179AF5A6-BD5B-4FAB-ABAD-CA6B50C2C5AAQ46082786-6EED8EEB-B78F-48F2-9552-68CC5D5FE93EQ47692179-78D117F3-0727-4386-A447-CE5FF2B669FBQ51701730-F8D04F93-1A3E-47ED-855F-D87154480DFDQ57216806-23954205-34DE-488E-A47A-6E9BCD8632FBQ68095306-D2E4736E-70C6-4ED3-916F-EAF40C45BE7DQ69840972-DE197A3E-5AEF-4AF3-B3CD-28E851072C1AQ69902425-0EA59753-B981-4B10-B642-1515CC725A43Q70153965-CBA74825-84BC-4DA4-AA30-A5A21A63A76DQ72194405-9D025FA4-BF42-442E-9C43-299D86C99F5EQ74586915-F3455D8E-4CFC-4521-9D7A-4E8AE4AD7CACQ81191262-81E3AD57-1918-40F0-9D2D-3FEF7786AA0BQ81434815-1434B6C8-6E93-450D-8BB4-8126C25B5C99Q81617975-550AC518-74E2-40EB-A699-BF2DC81F0638Q81648171-3A4B5E46-6E24-4294-9EE9-8E5783265F75
P50
description
researcher ORCID ID = 0000-0002-2338-6802
@en
name
F Zavala
@ast
F Zavala
@en
F Zavala
@es
F Zavala
@nl
type
label
F Zavala
@ast
F Zavala
@en
F Zavala
@es
F Zavala
@nl
prefLabel
F Zavala
@ast
F Zavala
@en
F Zavala
@es
F Zavala
@nl
P1153
7005364678
P31
P496
0000-0002-2338-6802